Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 7.31% |
AMGEN INC. | AMGN | 5.21% |
GILEAD SCIENCES, INC. | GILD | 4.73% |
REGENERON PHARMACEUTICALS | REGN | 4.36% |
VERTEX PHARMACEUTICALS | VRTX | 4.18% |
MODERNA INC | MRNA | 3.94% |
CORTEVA INC | CTVA | 3.29% |
BIOGEN IDEC, INC. | BIIB | 3.21% |
ILLUMINA INC | ILMN | 3.05% |
HORIZON THERAPEUTICS PLC | HZNP | 2.68% |
ASTRAZENECA PLC ADR | AZN | 2.65% |
SEAGEN INC | SGEN | 2.62% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.54% |
BIOMARIN PHARMACEUTICAL | BMRN | 2.35% |
ROYALTY PHARMA PLC- CL A | RPRX | 2.32% |
EXACT SCIENCES | EXAS | 2.13% |
INCYTE CORP | INCY | 2.11% |
VIATRIS INC | VTRS | 2.01% |
BIO-TECHNE CORP | TECH | 1.76% |
ICON PLC | ICLR | 1.75% |
UNITED THERAPEUTICS CORP | UTHR | 1.63% |
SAREPTA THERAPEU | SRPT | 1.63% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.51% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.48% |
CRISPR THERAPEUTICS AG | CRSP | 1.45% |
MEDPACE HOLDINGS | MEDP | 1.42% |
MIRATI THERAPEUT | MRTX | 1.38% |
KARUNA THERAPEUTICS INC | KRTX | 1.33% |
APELLIS PHARMACE | APLS | 1.32% |
IONIS PHARMACEUTICALS, IN | IONS | 1.27% |
HALOZYME THERAPEUTICS INC | HALO | 1.26% |
NATERA INC | NTRA | 1.24% |
EXELIXIS, INC. | EXEL | 1.23% |
BIONTECH SE-ADR | BNTX | 1.17% |
CYTOKINETICS INC | CYTK | 1.17% |
INTELLIA THERAPE | NTLA | 1.12% |
DENALI THERAPEUT | DNLI | 1.10% |
MARAVAI LIFESCIENCES HLDG | MRVI | 1.07% |
ARROWHEAD PHARMACEUTICALS | ARWR | 1.07% |
SYNEOS HEALTH, INC. | SYNH | 1.02% |
BEAM THERAPEUTICS INC | BEAM | 0.97% |
ULTRAGENYX PHARM | RARE | 0.93% |
BLUEPRINT MEDICI | BPMC | 0.88% |
GUARDANT HEALTH INC | GH | 0.77% |
BIOCRYST PHARM | BCRX | 0.76% |
VERACYTE INC | VCYT | 0.73% |
TWIST BIOSCIENCE CORP | TWST | 0.72% |
IRONWOOD PHARMAC | IRWD | 0.65% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.57% |
CAREDX INC | CDNA | 0.56% |
EDITAS MEDICINE | EDIT | 0.47% |
EMERGENT BIOSOLUTIONS INC | EBS | 0.43% |
NOVAVAX INC | NVAX | 0.39% |
BIOHAVEN LTD-W/I | BHVN | 0.39% |
FATE THERAPEUTIC | FATE | 0.25% |
Other (Cash, derivatives and other liabilities) | 0.46% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Fund Management (Europe) Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management.
© 2023 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.